Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FTRE is expected to report earnings to rise 2,100.00% to 43 cents per share on August 06
Q2'25
Est.
$0.44
Q1'25
Missed
by $0.39
Q4'24
Missed
by $0.24
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.27
The last earnings report on May 12 showed earnings per share of 1 cents, missing the estimate of 40 cents. With 411.48K shares outstanding, the current market capitalization sits at 424.63M.